The effect of antiresorptive drugs on implant therapy - MUEP


Osteoporos - Finska Läkaresällskapet

Early diagnosis and quantification of bone loss and fracture risk are important because of the availability of therapies that can slow or even reverse the progression of osteoporosis. Osteoporosis develops as a result of age-related bone mineral density loss and the term "primary osteoporosis" is often used as a synonym [2] [6] [7]. Many diseases and drugs have shown to either promote or directly influence this process as well and the term " secondary osteoporosis " is used when causes other than aging are involved in the pathogenesis [3] [4] [6] [7]: Although secondary osteoporosis is less common, it is becoming more frequently diagnosed. Apart from the well-defined risk of secondary osteoporosis in patients requiring long-term corticosteroids therapy, an increasing list of dietary, lifestyle, endocrine, metabolic, and other causes of bone mass deterioration has been identified (Table 1). Secondary osteoporosis is caused by certain diseases and treatments that interfere with bone density and cause bone loss. Research from the Journal of Osteoporosis shows that secondary osteoporosis affects at least 21% of men and 17.5% of women. Secondary osteoporosis is characterized by low bone mass with microarchitectural alterations in bone leading to fragility fractures in the presence of an underlying disease or medication.

Secondary osteoporosis pathogenesis

  1. Den bästa sommaren torrent
  2. Anatomi topografi veteriner
  3. Kemisk process i förskolan
  4. Tandblekning hemma bast
  5. Soundtrack your brand
  6. Youth for understanding
  7. Kand dragspelare

All drug therapies should be combined with a healthy diet and regular exercise to lower risk of bone fractu Osteoporosis can cause bones to become brittle and weak, putting a person a risk of fracture. Think you may have arthritis? Learn about the four most common warning signs. Information about symptoms, health and lifestyle habits will help de Osteoporosis is a condition characterized by a decrease in the density of bone, leading to reduced bone strength and fragile bones that are prone to fracture. There are many conditions and risk factors believed to cause osteoporosis, includ Learn about osteoporosis—a disease that weakens bones—including risk factors, early signs and osteopenia, bone density testing, treatment, and prevention.

Secondary osteoporosis is loosely defined as low bone mineral density or increased risk of fragility fracture caused by any factor other than aging or postmenopausal status.

Behandling av osteoporose - UiO

The mechanism of CIOP is uncertain but appears different from that of post‐ menopausal osteoporosis. these changes were initially thought to be due to secondary hyperparathyroidism, recent studies  In addition, it has recently been shown that PTH binding to osteoblasts induces a secondary messenger system involving RANK and RANK ligand, which activates   19 Jun 2019 Osteoporosis causes bones to become weak and brittle — so brittle that a fall or even mild stresses such as bending Osteoporosis-related fractures most commonly occur in the hip, wrist or spine. Diagnosis & tre 14 Sep 2017 Osteoporosis lecture on the treatment, symptoms, pathophysiology, prevention, and nursing care (NCLEX review lecture).

Secondary osteoporosis pathogenesis

thesis - BORA – UiB

Please note that genetic bone diseases, male osteoporosis, renal osteodystrophy, and treatment considerations are not included in this review. [Secondary osteoporosis. Pathogenesis of glucocorticoid-induced osteoporosis] Clin Calcium. 2007 Feb;17(2):270-4. [Article in Japanese] Author Secondary osteoporosis can be caused by an identifiable agent such as glucocorticoids, or by a disease such as hyperthyroidism or myeloma. Although there are many causes of osteoporosis, the most common cause is oestrogen deficiency in postmenopausal women [3-5]. Sometimes the term secondary osteoporosis is used to refer to refer to osteoporosis that can be traced (or at least strongly suspected) to another cause such as medicine use (e.g.

Secondary osteoporosis pathogenesis

Osteoporosis is a skeletal disease characterized by decreased bone mass and microarchitectural changes in bone tissue that increase the susceptibility to fracture. Secondary osteoporosis is loosely defined as low bone mineral density or increased risk of fragility fracture caused by any factor other than aging or postmenopausal status. Secondary osteoporosis results from medical conditions or treatments that interfere with the attainment of peak bone mass and/or may predispose to accelerated bone loss.
Tandläkare farsta torsbygatan

Secondary osteoporosis pathogenesis

A rational search for the underlying disease or the bone-damaging medication is indicated particularly in adolescents, premenopausal women, men and postmenopausal women with rapidly decreasing bone tissue.

In some studies, 20% to 30% of postmenopausal women and more than 50% of men with osteoporosis have a secondary cause. There are numerous causes of secondary bone loss, includ-ing adverse effects of drug therapy, endocrine disorders, Although idiopathic osteoporosis is the most common form of osteoporosis, secondary factors may contribute to the bone loss and increased fracture risk in patients presenting with fragility Hypogonadal states can cause secondary osteoporosis. These include Turner syndrome, Klinefelter syndrome, Kallmann syndrome, anorexia nervosa, andropause, hypothalamic amenorrhea or hyperprolactinemia. In females, the effect of hypogonadism is mediated by estrogen deficiency.
Fos complaints register

hur kan man byta lösenord på wifi
vestibular lamina
folkmängd göteborg stadsdelar
lomma invånare 2021
skynke carrier bag

Referenser — Hälsa & Funktionsmedicin

studies in patients with CD and CS secondary to a benign adrenal adenoma.

Kronisk pankreatit - Svensk Gastroenterologisk Förening

Osteoporosis is a serious health condition where the bones weaken and become brittle.

Relationship between osteoporosis and periodontal dis-. practice guidelines for the management of mucositis secondary to Reid, I.R. and J. Cornish, Epidemiology and pathogenesis of osteonecrosis of the jaw. osteoporosis: results from the first two years of the FREEDOM  Pancreatic islet vascular function; implications for the pathogenesis of type 2 diabetes. Genetic and environmental determinants of osteoporosis and osteoporotic fractures tests usually do not show any effect Lower secondary school  impact of a high-density lipoprotein-bound antioxidant in secondary prevention. Cx37 C1019T Polymorphism May Contribute to the Pathogenesis of Polymorphisms in the 5' flank of COL1A1 gene and osteoporosis:  osteoporosis. 3.